BB
Bhaskar Babu Koyyalamudi
About Bhaskar Babu Koyyalamudi
Data last updated:
Bhaskar Babu Koyyalamudi is a Director at Abvita Pharmaceuticals Private Limited (since 2020) and Director at Tairis Global Private Limited (since 2025). The companies operate in Chemicals. The largest current company by reported revenue is Abvita Pharmaceuticals Private Limited at ₹11.3 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Abvita Pharmaceuticals Private Limited U24299TG2020PTC143393 | Director | 01 Sep 2020 | 2020 | ₹11.3 Lakh (FY 2023) | Active |
| Tairis Global Private Limited U78300TS2025PTC199895 | Director | 14 Jun 2025 | 2025 | Active |
Board colleagues of Bhaskar Babu Koyyalamudi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Apparao Pudi | 02351564 | Abvita Pharmaceuticals Private Limited | Director |
| Venkata Sai Chaithanya Pudi | 08858196 | Abvita Pharmaceuticals Private Limited | Director |
| Jaya Lalitha Koyyalamudi | 11155080 | Tairis Global Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Bhaskar Babu Koyyalamudi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bhaskar Babu Koyyalamudi
Bhaskar Babu Koyyalamudi currently holds 2 directorships: Abvita Pharmaceuticals Private Limited (Director, since 01 Sep 2020, revenue ₹11.3 Lakh (FY 2023)); Tairis Global Private Limited (Director, since 14 Jun 2025).
Bhaskar Babu Koyyalamudi was first appointed on 01 Sep 2020 as Director at Abvita Pharmaceuticals Private Limited. The most recent appointment on record is 14 Jun 2025 at Tairis Global Private Limited.
The current boards of Bhaskar Babu Koyyalamudi's companies include Apparao Pudi (Abvita Pharmaceuticals Private Limited), Venkata Sai Chaithanya Pudi (Abvita Pharmaceuticals Private Limited), Jaya Lalitha Koyyalamudi (Tairis Global Private Limited).